Symptomtext
Patient received an expired dose of fluzone QIV with no reported adverse event; Initial information was received on 14-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 57 years old male patient received an expired dose of fluzone qiv with no reported adverse event after receiving influenza quadrival a-b multidose vaccine preserved [Fluzone]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Oct-2022, the patient received a dose of 0.5 ml suspect influenza quadrival a-b multidose vaccine preserved (suspection for injection) (Frequency: once) (lot number: UT7316NA,Expiration date:30-Jun-2022)(strength: unknown) via unknown route in unknown administration site for prophylactic vaccination (immunization) . On 12-Oct-2022 the patient received an expired dose of fluzone qiv with no reported adverse event (expired product administered) (latency: same day) following the administration of influenza quadrival a-b multidose vaccine preserved. Action taken : not applicable. At time of reporting, the outcome was Unknown for the event patient received an expired dose of fluzone qiv with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.